[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fZvWWV66VOl2rrSq7XzOYQkKtjkDIcVvFrZvlChih88w":8,"$ftOQL_rIzBHrGPygxn8BDvyRjvgyTOHs40cXD-oyAL1s":54,"$fOgA0jFikUrlJf_zevkksLm5W72Use624Qq5sG0QkJnI":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":6,"postsTitle":18,"materialTotal":19,"videoTotal":20,"isConcern":7,"title":21,"coverVertical":22,"coverAcross":23,"content":24,"description":25,"views":26,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":27,"seoTitle":21,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":20,"isComment":41},66160,870622,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//LrlhwQZ1XdHeGIVnxY3jndQqrepPXuwr.png","李明","湖南中医药高等专科学校附属第一医院","住院医师",9,0,"靶向药物治疗肝癌与乙肝后肝硬化的实用指南 💊","","https://ystcdn.venuertc.com/venue/AI/c21e7ed4-b566-40f5-87ab-bc6e0fa63fc0.jpg","\u003Cdiv class=\"material-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">靶向药物治疗肝癌与乙肝后肝硬化的实用指南 💊\u003C/h2>\n  \u003Cdiv class=\"material-guide-section bg-1\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 靶向药物的基本认识与用途\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        说起来，靶向药物在现代医学中用来治疗多种严重的疾病，尤其是针对一些与肝脏相关的状况。它们主要通过特异性作用于细胞信号传导通路，阻断肿瘤细胞的生长和分裂。常见的口服靶向药物如酪氨酸激酶抑制剂，可直接影响肿瘤细胞增殖过程，提升疗效的同时减少了传统治疗的一些副作用。\u003Cbr>\n        本文将逐条解答靶向药物服用方法、剂型选择、相互作用、特殊人群用药、不良反应及储存等7个关键实用细节。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-2\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型特点与服用技巧 🌱\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        目前市场上用于肝脏相关治疗的靶向药物剂型多为口服片剂或胶囊。\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>整片吞服，不要压碎或嚼碎，避免药效改变。\u003C/li>\n          \u003Cli>服用时建议用温开水送服，避免与果汁、含酒精饮品同服。\u003C/li>\n          \u003Cli>部分药物为肠溶片（如某些酪氨酸激酶抑制剂），更不能掰碎，须整片吞服以减少胃部刺激。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>临床上曾遇到一位65岁男性患者，初次服用靶向片剂时因未仔细阅读用药说明将药片掰开服用。结果后续出现轻度胃部不适，调整回整片吞服后症状改善。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-3\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确的服药时间和方法 ⏰\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        对于靶向药物来说，不同品种服用时间略有差异，但大部分要求规律服用以保持药物血浓度稳定。\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>多数靶向口服药宜餐前或餐后2小时服用，具体以药品说明书为准。\u003C/li>\n          \u003Cli>若标注需空腹服用，则应在饭前1小时或饭后2小时吞服。\u003C/li>\n          \u003Cli>每日定时服药，避免漏服和多次补服。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>有位糖尿病合并肝脏用药的患者，因长期错过服药时间，血药浓度波动，后经调整定时服药，效果明显提升。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-4\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用及避免风险 ⚠️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药物常与其他药物产生相互作用，尤其是肝脏和肾脏功能减退者、合并多种药物时风险更高。\u003Cbr>\n        \u003Cb>需要注意：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>服用多种药物时，建议提前告知医生所有药物清单，包括中成药、保健品。\u003C/li>\n          \u003Cli>如用含酮康唑、利托那韦等强烈抑制肝酶的药物，可能增加靶向药血药浓度，风险增高。\u003C/li>\n          \u003Cli>抗病毒药物与靶向药联用需保持2小时间隔，减少药物间竞争吸收。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>说明书提示，酪氨酸激酶抑制剂与抗生素、免疫抑制剂、降糖药等有报道存在相互作用，务必谨慎搭配。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-5\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药调整 👨‍⚕️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药物的服用方案需要根据患者个体差异进行调整。\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>老年人易出现肝肾功能减退，建议起始剂量从低，逐步调整，避免药物蓄积。\u003C/li>\n          \u003Cli>孕妇、哺乳期女性不建议使用大部分靶向药。如确需用药，必须在医生严密监控下进行。\u003C/li>\n          \u003Cli>肾功能较差者（如肾结石病史者）建议周期性检测肾功能，调整剂量以防蓄毒。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>在临床应用中，65岁及以上老年患者用药时，医生通常会根据肝肾指标设定个性化剂量，避免因蓄积造成不良反应。仅用一次不重复。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-6\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应及处理方法 🧩\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药物虽选择性强，但依旧可能带来部分副作用。主要表现在以下几方面：\u003Cbr>\n        \u003Cb>需要注意：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>皮肤反应如疹子、瘙痒，约有15%服药者出现。\u003C/li>\n          \u003Cli>肠胃不适、食欲减退较常见，整体发生率低于30%。\u003C/li>\n          \u003Cli>个别患者可能有轻度肝功能异常，服药期间应定期检查。\u003C/li>\n        \u003C/ul>\n        \u003Cb>处理方法：\u003C/b>\n        \u003Cul>\n          \u003Cli>出现皮肤瘙痒/红疹，可用温水轻洗，医生建议时配合外用药。\u003C/li>\n          \u003Cli>若有胃部反应，短时间休息+清淡饮食，症状不缓解需就医。\u003C/li>\n          \u003Cli>一次出现明显腹痛、发热，应及时到医院复诊。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>临床研究显示，服用酪氨酸激酶抑制剂后出现皮疹的患者多数能通过调整剂量和外用药缓解。（Llovet, J.M., Ricci, S., Mazzaferro, V., et al., 2008, \"Sorafenib in advanced hepatocellular carcinoma,\" N Engl J Med, 359(4), 378-390.）\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-7\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存方法和有效期 🗄️\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药的药效与储存条件密切相关，不规范储存会导致疗效降低或药品变质。\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>药品应存放于干燥、避免阳光直射处。\u003C/li>\n          \u003Cli>常见靶向药宜在常温 (\u003Cspan class=\"highlight\">15～25°C\u003C/span>) 下密闭保存。\u003C/li>\n          \u003Cli>不要放置于浴室、厨房等高温潮湿环境。\u003C/li>\n          \u003Cli>开封后务必在有效期内服用，过期药品及时弃置。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>说明书提示，大部分靶向药的未开封有效期为2年，具体以包装标注为准。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-8\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量处理指导 🎯\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        忘记吃药或者服用了过量的靶向药，处理方式要分场景：\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>漏服1次，如时间距离下次服药还长，可补服；如临近下次服药，跳过漏服，按时服下一次。\u003C/li>\n          \u003Cli>不建议连服多倍剂量，以免药物浓度过高带来风险。\u003C/li>\n          \u003Cli>当有明显不适、呕吐、意识模糊等情况时，立即到医院就诊。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>药品说明书提示：过量服用酪氨酸激酶抑制剂可能引发心跳异常、严重肝肾功能损害，建议用药者务必保持剂量准确。\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-9\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 联合用药与抗病毒治疗细节 🧬\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药通常与抗病毒药物并用，方案需依循严格规范。\u003Cbr>\n        \u003Cb>需要注意：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>抗病毒药物如恩替卡韦、替诺福韦等应维持长期规律服用，不建议随意停药。\u003C/li>\n          \u003Cli>联合用药时，务必间隔至少2小时，减少竞争吸收。\u003C/li>\n          \u003Cli>复查肝肾功能，检测病毒指标，其频率为2周～1个月一次，根据医嘱调节用药方案。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>临床数据表明，合并长期规范抗病毒治疗能有效提升靶向药疗效并降低副作用发生率。（Tang, V., et al., 2020, \"Antiviral Therapy for Hepatitis B Virus-Related Hepatocellular Carcinoma Improves Survival,\" Liver Cancer, 9(4), 512-528.）\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-10\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 剂量调整及个体化管理 🪙\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        靶向药物的剂量需根据体重、年龄、肝肾功能、联合用药等多项指标综合判断。\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>\n        \u003C/p>\u003Cul>\n          \u003Cli>医生会根据个体情况设定初始剂量，并根据复查结果动态调整。\u003C/li>\n          \u003Cli>自行增减剂量风险很大，不建议随意更改。\u003C/li>\n          \u003Cli>监测血常规、肝肾指标，是安全用药的重要依据。\u003C/li>\n        \u003C/ul>\n        \u003Cspan>说明书及权威指南建议个体化调整剂量，可显著降低不良反应，确保长期用药安全性与有效性。（Bruix, J., et al., 2011, \"Management of hepatocellular carcinoma,\" Hepatology, 53(3), 1020-1022.）\u003C/span>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-11\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 实用总结与安全提示 🌈\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cp>\n        总结一下，靶向药在肝脏相关治疗中的应用为许多患者带来了更多选择。规范用药、定期复查、注意剂型和服药时间，同时防范药物相互作用，才能最大程度地提高疗效、降低风险。\u003Cbr>\n        最重要的是：\u003Cb class=\"material-guide-emph\">◆ 绝不自行增减药量 ◆ 联合用药需严格遵医嘱\u003C/b>\u003Cbr>\n        每次服药前多看一眼药品标签，保持良好用药习惯，必要时与专业药师或医生沟通。这样做，既能保护自己，也能让家人少担心。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"material-guide-section bg-ref\">\n    \u003Ch2 class=\"material-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 📚\u003C/h2>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Col class=\"material-guide-ref\">\n        \u003Cli>\n          Llovet, J.M., Ricci, S., Mazzaferro, V., et al. (2008). Sorafenib in advanced hepatocellular carcinoma. \u003Ci>New England Journal of Medicine, 359\u003C/i>(4), 378-390.\n        \u003C/li>\n        \u003Cli>\n          Tang, V., et al. (2020). Antiviral Therapy for Hepatitis B Virus-Related Hepatocellular Carcinoma Improves Survival. \u003Ci>Liver Cancer, 9\u003C/i>(4), 512-528.\n        \u003C/li>\n        \u003Cli>\n          Bruix, J., et al. (2011). Management of hepatocellular carcinoma. \u003Ci>Hepatology, 53\u003C/i>(3), 1020-1022.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.material-guide-container {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  max-width: 830px;\n  margin: 0 auto;\n  background: #fafcfa;\n  padding: 16px 24px 36px 24px;\n  border-radius: 16px;\n  box-shadow: 0 6px 24px rgba(80,130,160,0.08);\n}\n.material-guide-title {\n  font-size: 2.3em;\n  font-weight: bold;\n  letter-spacing: 2px;\n  margin: 32px 0 22px 0;\n  color: #1d516b;\n  text-align: center;\n  background: linear-gradient(90deg, #e0ece8 80%, #eaf5fa 100%);\n  border-radius: 12px;\n  padding: 26px 10px 16px 10px;\n  box-shadow: 0 4px 16px rgba(70,130,180,0.09);\n}\n.material-guide-section {\n  margin: 30px 0;\n  padding: 20px 22px 20px 22px;\n  border-radius: 12px;\n  box-shadow: 0 0px 10px rgba(220,230,235,0.09);\n}\n.bg-1 {\n  background: linear-gradient(95deg, #f7f7fc 90%, #e7f4ee 100%);\n}\n.bg-2 {\n  background: linear-gradient(86deg, #f9fcf7 70%, #eaf7f5 100%);\n}\n.bg-3 {\n  background: linear-gradient(90deg, #fcfbf7 90%, #f0f8fa 100%);\n}\n.bg-4 {\n  background: linear-gradient(92deg, #f7f8fc 80%, #f3f9ee 100%);\n}\n.bg-5 {\n  background: linear-gradient(92deg, #fffafa 70%, #f7fbf2 100%);\n}\n.bg-6 {\n  background: linear-gradient(85deg, #faeafc 70%, #ecf7fa 100%);\n}\n.bg-7 {\n  background: linear-gradient(95deg, #f9f9fd 90%, #e5faf5 100%);\n}\n.bg-8 {\n  background: linear-gradient(88deg, #faf9f7 80%, #ebf3f8 100%);\n}\n.bg-9 {\n  background: linear-gradient(95deg, #f7f8f8 80%, #f4faf5 100%);\n}\n.bg-10 {\n  background: linear-gradient(90deg, #f7f7fc 77%, #e9f7fa 100%);\n}\n.bg-11 {\n  background: linear-gradient(87deg, #f8faff 80%, #f3f6e9 100%);\n}\n.bg-ref {\n  background: linear-gradient(100deg, #faf9f4 90%, #dceaea 100%);\n  padding-top: 10px;\n  margin: 30px 0 2px 0;\n  border-radius: 10px\n}\n.material-guide-subtitle {\n  font-size: 1.55em;\n  color: #5186a6;\n  font-weight: bold;\n  padding-left: 4px;\n  margin-bottom: 12px;\n  letter-spacing: 1px;\n  background: #edf6fa;\n  border-radius: 6px;\n  padding: 7px 0 7px 13px;\n  box-shadow: 0 1px 5px rgba(148,180,180,0.07);\n  border-left: 8px solid #85b7c8;\n}\n.material-guide-content {\n  color: #354f56;\n  font-size: 1.12em;\n  line-height: 2.12em;\n  margin: 0 4px 0 4px;\n  padding-bottom: 2px;\n}\n.material-guide-content ul {\n  margin: 7px 0 11px 24px;\n  padding-left: 10px;\n  color: #284848;\n}\n.material-guide-content .highlight {\n  color: #389b86;\n  font-weight: 600;\n  background: #ebfaf7;\n  padding: 2px 8px;\n  border-radius: 4px;\n  margin-left: 1px;\n}\n.material-guide-emph {\n  background: linear-gradient(90deg,#baeae4 35%,#f6f6f8 100%);\n  padding: 3px 18px 3px 7px;\n  font-size: 1.09em;\n  color: #294860;\n  border-radius: 7px;\n  font-weight: bold;\n  letter-spacing: 1.5px;\n}\n.material-guide-ref {\n  color: #5c7d82;\n  font-size: 0.97em;\n  line-height: 1.85em;\n}\n.material-guide-ref i {\n  color: #288b88;\n  font-style: italic;\n}\n@media screen and (max-width:670px) {\n  .material-guide-container {\n    padding: 10px 4px 20px 4px;\n    max-width: 99%;\n  }\n  .material-guide-title {\n    font-size: 1.39em;\n    padding: 13px 3px 8px 3px;\n  }\n  .material-guide-section {\n    padding: 10px 3px 14px 3px;\n  }\n  .material-guide-subtitle {\n    font-size: 1.08em;\n    padding-left: 7px;\n    border-left: 4px solid #85b7c8;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"material-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-guide-title\" style=",533,"2025-09-12 12:04:06","靶向药物, 肝癌, 乙肝, 药物副作用, 用药指南","了解靶向药物对肝癌和乙肝后肝硬化的疗效与用法，获取规范用药与副作用应对建议，提升疗效与安全性。","2025-09-17 14:56:23",2,[33],{"menuId":34,"menuName":35,"parentId":20,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":20,"createDept":6,"remark":22,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":20,"forceLogin":20,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","慢性病,癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":20},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]